Ketogenic (very low-carb) diet
Last reviewed 25 August 2026 · Evidence-graded review — see Methodology
Cut carbohydrates to roughly 50 grams a day and the body shifts into ketosis, burning fat for fuel instead of glucose. The diet reliably takes weight off quickly and lowers HbA1c in people with type 2 diabetes. What it does not have is long-term evidence in healthy adults, and the observational data on low-carb eating is genuinely mixed. On outcomes people actually care about, it currently earns a weak grade.
Short-term randomised trials are consistent: a classic 2004 trial found a low-carbohydrate ketogenic diet produced more weight loss at six months than a low-fat diet, though the gap narrowed by twelve (Yancy et al., Ann Intern Med 2004). A 2022 systematic review of randomised trials in type 2 diabetes found very-low-carb diets improved HbA1c and triglycerides at six to twelve months, with larger early weight loss. The trouble is what happens after the horizon of a trial ends. The best cohort data we have suggests a U-shaped relationship between carbohydrate intake and mortality: people eating the lowest amounts of carbohydrate, especially when the fat and protein came from animals, had modestly higher all-cause mortality over 25 years than moderate consumers (Seidelmann et al., Lancet Public Health 2018). That is observational, not proof of harm, but it is the opposite of the reassurance a longevity claim needs.
Doing it: If you use it to lose weight or manage diabetes, treat it as a bounded experiment, not a permanent identity: aim for a defined period, keep unsaturated fat sources (olive oil, nuts, fish) ahead of bacon, and if you take glucose-lowering or blood-pressure medication, do the induction under medical supervision. In the long run, no trial shows keto outperforming a Mediterranean-style diet, and the Mediterranean diet has outcome data keto does not.
Who it suits: Adults with obesity or type 2 diabetes who want a structured, quick-start option and can be monitored. Not for anyone with a history of disordered eating, gallstone disease, or kidney disease, and not for people who cannot sustain it long term.
Sources
- Yancy WS, et al. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med. 2004;140:769–777.
- Parry-Strong A, et al. Very low carbohydrate (ketogenic) diets in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2022;24:2431–2442.
- Seidelmann SB, et al. Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis. Lancet Public Health. 2018;3:e419–e428.
Next in diet: Fibre intake →
Prefer to start with what a blood test can tell you? All 48 diagnostic tests, ranked →